These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 16937393

  • 1. Escitalopram in the treatment of anxiety symptoms associated with depression.
    Bandelow B, Andersen HF, Dolberg OT.
    Depress Anxiety; 2007; 24(1):53-61. PubMed ID: 16937393
    [Abstract] [Full Text] [Related]

  • 2. A prospective study of escitalopram in the treatment of major depressive episodes in the presence or absence of anxiety.
    Olié JP, Tonnoir B, Ménard F, Galinowski A.
    Depress Anxiety; 2007; 24(5):318-24. PubMed ID: 17041922
    [Abstract] [Full Text] [Related]

  • 3. [Efficacy of escitalopram vs paroxetine on severe depression with associated anxiety: data from the "Boulenger" study].
    Chauvet-Gélinier JC.
    Encephale; 2010 Oct; 36(5):425-32. PubMed ID: 21035633
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.
    Fraguas R, da Silva Telles RM, Alves TC, Andrei AM, Rays J, Iosifescu DV, Wajngarten M.
    Contemp Clin Trials; 2009 May; 30(3):205-11. PubMed ID: 19470312
    [Abstract] [Full Text] [Related]

  • 5. Relapse prevention and residual symptoms: a closer analysis of placebo-controlled continuation studies with escitalopram in major depressive disorder, generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder.
    Bech P, Lönn SL, Overø KF.
    J Clin Psychiatry; 2010 Feb; 71(2):121-9. PubMed ID: 19961809
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 7. Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.
    Demyttenaere K, Andersen HF, Reines EH.
    Int Clin Psychopharmacol; 2008 Sep; 23(5):276-86. PubMed ID: 18703937
    [Abstract] [Full Text] [Related]

  • 8. Citalopram and suicidality in adult major depression and anxiety disorders.
    Pedersen AG.
    Nord J Psychiatry; 2006 Sep; 60(5):392-9. PubMed ID: 17038305
    [Abstract] [Full Text] [Related]

  • 9. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
    Bose A, Korotzer A, Gommoll C, Li D.
    Depress Anxiety; 2008 Sep; 25(10):854-61. PubMed ID: 18050245
    [Abstract] [Full Text] [Related]

  • 10. Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.
    Papakostas GI, McGrath P, Stewart J, Charles D, Chen Y, Mischoulon D, Dording C, Fava M.
    Psychiatry Res; 2008 Oct 30; 161(1):116-20. PubMed ID: 18755514
    [Abstract] [Full Text] [Related]

  • 11. A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.
    Boulenger JP, Huusom AK, Florea I, Baekdal T, Sarchiapone M.
    Curr Med Res Opin; 2006 Jul 30; 22(7):1331-41. PubMed ID: 16834832
    [Abstract] [Full Text] [Related]

  • 12. Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression.
    Vaccarino AL, Evans KR, Sills TL, Kalali AH.
    Depress Anxiety; 2008 Jul 30; 25(12):1006-13. PubMed ID: 18800370
    [Abstract] [Full Text] [Related]

  • 13. Effective dose of escitalopram in moderate versus severe DSM-IV major depression.
    Bech P, Andersen HF, Wade A.
    Pharmacopsychiatry; 2006 Jul 30; 39(4):128-34. PubMed ID: 16871468
    [Abstract] [Full Text] [Related]

  • 14. Escitalopram therapy for major depression and anxiety disorders.
    Baldwin DS, Reines EH, Guiton C, Weiller E.
    Ann Pharmacother; 2007 Oct 30; 41(10):1583-92. PubMed ID: 17848424
    [Abstract] [Full Text] [Related]

  • 15. Escitalopram in the treatment of major depressive disorder in primary-care settings: an open-label trial.
    Chokka P, Legault M.
    Depress Anxiety; 2008 Oct 30; 25(12):E173-81. PubMed ID: 19006260
    [Abstract] [Full Text] [Related]

  • 16. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA, Prakash A, Arnold LM, Aaronson ST, Mallinckrodt CH, Wohlreich MM.
    Curr Med Res Opin; 2007 Jun 30; 23(6):1303-18. PubMed ID: 17559729
    [Abstract] [Full Text] [Related]

  • 17. Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials.
    Nelson JC.
    Depress Anxiety; 2010 Jun 30; 27(1):12-8. PubMed ID: 20013987
    [Abstract] [Full Text] [Related]

  • 18. [Severe forms of depression: the efficacy of escitalopram].
    Spadone C.
    Encephale; 2009 Apr 30; 35(2):152-9. PubMed ID: 19393384
    [Abstract] [Full Text] [Related]

  • 19. Mood and neuropsychological changes in women with midlife depression treated with escitalopram.
    Wroolie TE, Williams KE, Keller J, Zappert LN, Shelton SD, Kenna HA, Reynolds MF, Rasgon NL.
    J Clin Psychopharmacol; 2006 Aug 30; 26(4):361-6. PubMed ID: 16855452
    [Abstract] [Full Text] [Related]

  • 20. Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study.
    Brown ES, Howard C, Khan DA, Carmody TJ.
    Psychosomatics; 2012 Aug 30; 53(1):75-80. PubMed ID: 22221724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.